Objectives: The survey and the Association of the Medical Scientific Societies in Germany (AWMF) criteria had been developed to overcome problems associated with tender point criterion of the American College of Rheumatology (ACR) (lacking validation for clinical diagnosis, inconsistent use by rheumatologists, and nonrheumatologists) for the clinical diagnosis of fibromyalgia syndrome (FMS). We compared the concordance between these 3 criteria.
A
lthough not developed as a diagnostic tool, the American College criteria (ACR) for the classification of fibromyalgia syndrome (FMS), namely the presence of chronic widespread pain (CWP) and at least 11 of 18 painful tender points (TP) on manual pressure, 1 have become the de facto diagnostic criteria used for basic research and clinical studies on FMS. 2 A major problem with the TP criterion for the definition of FMS is its bias toward the selection of females and individuals with high levels of physical and psychologic distress, 3, 4 out of the 10 -26% of persons with CWP in the general population. 5 There is general agreement between medical disciplines that the symptom of ''chronic widespread pain (CWP)'', as defined by the ACR (axial plus upper and lower body plus left-sided and right-sided pain) 1 or by epidemiologic criteria (pain in the axial skeleton and all 4 extremities), 5 is essential for the clinical diagnosis of FMS. If other symptoms such as fatigue and nonrestorative sleep or physical findings such as tenderness on pressure on at least 11/18 tender points should be used as adjuncts for the clinical diagnosis of FMS is under debate. Wolfe claimed that clinicians should stop using TP examination (TPE) for the clinical diagnosis of FMS. 6 In contrast Harth and Nielson concluded from a narrative review of the literature that TPE is useful in the clinical assessment of FMS. 7 Alternative tools for the clinical diagnosis of FMS had been suggested. Katz et al 2 and Wolfe 8 made the clinical diagnosis of FMS by clinician's experience considering clinical criteria such as pain, fatigue, sleep disturbance, comorbidity, and psychosocial variables without specifying the rules of diagnosis. Wolfe developed a questionnaire, named the Regional Pain Scale (RPS) that assesses 19 articular and nonarticular body regions for the presence of pain. He suggested survey criteria characterized by the combination of at least 8/19 painful body areas on the RPS and a score of Z6 on an 11 point visual analogue scale for fatigue. This approach correctly identified most patients diagnosed with FMS by their rheumatologists based on the clinical criteria mentioned above. 8 Within 1 rheumatologic practice the concordance rates of the ACR, survey, and clinical criteria of FMS were between 72% to 75%. 2 These data have not been replicated in other settings.
Coordinated by the Association of the Medical Scientific Societies in Germany (AWMF) and the German Interdiscplinary Association for Pain Therapy, 10 German medical and psychologcial scientific societies (general medicine, rheumatology, pain medicine, orthopaedic surgery, psychiatry, psychosomatic medicine, neurology, psychology), and 2 self-help organisation developed an evidence-based and consensus-based guideline on the classification, diagnosis, and therapy of FMS. 9 The guideline classified FMS as a functional somatic syndrome. 10 Thus, the clinical diagnosis should be based on symptoms and the exclusion of somatic diseases which sufficiently explain CWP by carrying out a complete clinical examination and defined routine blood tests. 9 On the basis of studies on the main symptoms of FMS-patients in different clinical settings, [11] [12] [13] these additional symptoms besides CWP are required for the clinical diagnosis of FMS: sleep disturbances and mental or physical fatigue and feeling of swelling or stiffness of the hands or feet or legs. These criteria were supported by the consensus committee, but have not been validated in epidemiologic or clinical studies.
The aim of this study was to compare the concordance of the 3 diagnostic criteria in different clinical settings to overcome potential selection and investigator bias. Furthermore, we assessed if the different diagnostic criteria would lead to different sociodemographic and clinical profiles of the patients diagnosed with FMS.
MATERIALS AND METHODS

Settings and Investigators
The study was carried out in 1 rheumatologic practice (WB), 1 outpatient department of rheumatology of a district hospital (SH supervised by HvW), 1 pain medicine practice (HKB), 1 university pain clinic (FP), 1 psychosomatic medicine practice (MG), 1 psychosomatic medicine universitarian outpatient department (WH), and 1 department of integrative medicine of an academic teaching hospital (JL). SH was a junior physician who was trained for this project for his doctoral thesis. The other investigators were experienced clinicians who were working with FMS-patients for at least 10 years. The patients underwent a complete physical assessment by these researchers. The investigators had been instructed to carry out TPE according to the manual tender point survey protocol. 14 
Patients
Consecutive patients referred to the settings detailed above for the evaluation and/or management of CWP, with and without established diagnosis of FMS, were included during the period of January to June 2009. Patients with somatic diseases, for example active inflammatory rheumatic disease, sufficiently explaining CWP, diagnosed by clinical examination, and laboratory testing, were excluded. Patients with inactive somatic diseases, for example inflammatory rheumatic disease in remission not explaining CWP, were included.
Diagnoses of FMS were made according to the ACR (CWP as defined by the ACR and tenderness on pressure of at least 11/18 TP), survey (RPS score Z8/19 and fatigue score Z6/10 on a visual analogue scale in the last week), and AWMF-criteria (CWP defined as axial pain and pain in all 4 extremities assessed by medical history and/or pain drawing and the report of sleep disturbances and fatigue and feeling of swelling or stiffness of the hands or feet or face in the last 3 mo with a score scale Z1/10 on a numeric rating scale on a self-constructed symptom questionnaire).
All patients gave their informed consent to data collection and analysis. The study was approved by the respective regional and institutional ethics committees if required.
Questionnaires
If patients reported a diagnosis of FMS or if FMS was suspected by medical history and/or pain drawings, patients were asked to complete these questionnaires: A selfconstructed sociodemographic and medical questionnaire assessing age, sex, duration of CWP and FMS-diagnosis, partnership and professional status and the symptoms sleep disturbances, mental and physical fatigue, feeling of swelling or stiffness of the hands, feet, and legs on an 11 point a numeric rating scale; the RPS 8, and the Patient Health Questionnaire PHQ 9 and 15. 15, 16 The PHQ is a self-administered version of the Primary Care Evaluation of Mental Disorders diagnostic instrument for common mental disorders. To assess somatic symptoms and depressed mood, the respective parts of the validated German version of the PHQ were used. 17 The PHQ-15 comprises 13 somatic symptoms from the PHQ, each symptom scored from 0 (''not bothered at all'') to 2 (''bothered a lot''). PHQ-15 scores of 5,10,15 represent cutoff points for low, medium, and high somatic symptom severity, respectively. The usefulness of the PHQ-15 in screening for somatisation and in monitoring somatic symptom severity in clinical practice and research had been shown in numerous studies. 16 The PHQ-9 is the depression module of the PHQ, which scores each of the 9 DSM-IV criteria as ''0'' (not at all) to ''3'' (nearly every day). Validity has been assessed against an independent structured mental health professional interview. PHQ-9 scores of 0 to 4 indicate no depression, 5 to 9 mild depression, 10 to 14 moderate depression, 15 to 19 moderately severe depression, and 20 to 27 severe depression. 15 As items of the PHQ 9 and 15 comprise key symptoms of FMS, namely pain, sleep disturbances, and fatigue, we calculated modified sum scores of these questionnaires by removing the items c (sleep problems), d (lack of energy), and g (trouble concentrating) from the PHQ 9 and the items b (back pain) and c (pain in extremities) from the PHQ 15. Item d (menstrual cramps or other problems with periods) was coded 0 for men.
Statistical Analyses
The concordance of the 3 different diagnostic criteria was calculated by the percentage of the sum of positive and negative agreements between 2 pairs of diagnostic criteria each. Up to 25% of missing items in the PHQ 9 and 15 were substituted by the individual median. If more than 25% items were missing, the questionnaire was excluded from analysis. Missing items in the RPS and symptom questionnaire were coded with 0.
To assess differences between groups, we compared mean scores of continuous demographic and clinical variables by analyses of variance (ANOVAS) with posthoc 2 group comparisons by the Dunnett-T3 test. w 2 analysis was used for categorical variables. All tests were 2-tailed, with the a-value set at 0.01 because of multiple comparisons. All analyses were conducted with SPSS Version 17.0 statistical package.
RESULTS
One of 311 patients approached refused to take part in the study. Three hundred ten patients participated. Of these, 16 patients were excluded because no complete data set of the 3 diagnostic criteria were available. Furthermore, 2 patients who reported to be diagnosed with FMS were excluded because they did not meet any of the 3 diagnostic criteria. Thus, 292 patients were included into analysis. In 81/292 (27.7%) of the patients FMS was diagnosed for the first time. The sex ratio of the patients, the low educational level, the high levels of work disability, and physical and somatic distress of most of the patients of the study sample are consistent with known characteristics of FMS-patients in clinical settings and studies 2 (Table 1 ). Yet, it is important to note that FMS was diagnosed also in a minority of highly educated patients and in patients with low levels of reported additional somatic and psychologic distress. Only few significant differences of sociodemographic and clinical characteristics of the patients were found between the study centers. The outpatient psychosomatic department recruited more male patients than the other study centers. The percentage of patients with a high educational level was larger in the department of integrative medicine than in the other study centers (details not reported).
The intercorrelationships of the 3 diagnostic groups are shown graphically in Figure 1 . Seventy-one percent of the patients were diagnosed with FMS by all 3 methods. Isolated positive cases were noted (1.4%, 3.1%, and 2.0% respectively, diagnosed by AWMF only, by survey only, and by ACR criteria only). AWMF negative cases were all owing to lacking CWP defined as pain axially and in all 4 extremities. Survey negative cases were all owing to a fatigue score <6. A majority of ACR negative cases (71%) were owing to a TP count <11. Twenty-nine percent ACRnegative cases did not meet the ACR-criterion of CWP.
AWMF and ACR were concordant in 86.6% (range 77.1 to 100), AWMF and survey criteria were concordant in 78.8% (range 66.7 to 90.2), and survey and ACR-criteria were concordant in 79.5% (69.2 to 86.9) of the cases. There were no significant overall differences in the concordances of the 3 diagnostic criteria between the study centers ( Table 2 ). There were no significant differences of the concordances of the 3 diagnostic criteria between patients with initial and established diagnosis of FMS (Table 3) . Patients who were positive in all 3 diagnostic criteria reported higher levels of depressed mood and somatic symptom severity than patients positive only in AWMF and ACR criteria (Table 4) .
DISCUSSION
Summary of Main Results
Alternative criteria for the clinical diagnosis of FMS had been developed, to overcome problems associated with the use of the tender point criterion of the ACR for the clinical diagnosis, and to offer nonrheumatologists alternatives of diagnosing FMS without TPE. These alternative criteria are the survey criteria and the criteria of the Association of the Medical Scientific Societies in Germany. We compared the concordance of these 3 criteria in different clinical settings in patients referred for the 
Agreement With Other Studies
Katz et al reported a concordance of survey and ACR criteria of 72.3%, 2 which was comparable with the 1 in our study with 79.3% (range 71.4 to 86.7). The concordance of the 3 diagnostic criteria in our study was higher than between the 3 diagnostic criteria in the study of Katz et al (72% vs. 33%).
Why Are Alternative Criteria for the Clinical Diagnosis of FMS Required?
There are several practical and scientific reasons to develop alternative criteria for the clinical diagnosis of FMS: a. A standardized manual tender point survey is available, 14 but this protocol is not used in rheumatologic practice and in most clinical studies on FMS. Even with the standardization of manual TPE, there is the risk of ''the harder you press (the more you believe?), the more FM you find. '' 6 b. The reliability and validity of the TP examination outside the context of FMS-specialized rheumatologic settings had never been tested. 3 c. FMS is not a disease exclusively diagnosed and treated by rheumatologists. Patients are also diagnosed and treated by general practitioners, pain physicians, or psychiatrists. [18] [19] [20] [21] TPE is largely ignored in these settings. Nonrheumatologists, had not been trained for TPE within their residency program. Moreover, TPE would be time consuming in these settings. Even if a competent physician of whatever discipline who is able to conduct a thorough medical examination could be taught a standardized manual TPE, the time to carry out this examination could be used to extract a more comprehensive psychosocial history. Therefore, the development of alternative diagnostic criteria without TPE had been demanded by these medical disciplines. 19 d. Although increased tenderness or hyperalgesia/allodynia to pressure stimuli had been replicated by other more objective ways of assessment, 4,22 its relevance and specificity for the diagnosis of FMS had been questioned. 23 
Differences Between the Diagnostic Criteria of FMS Available
There are some differences between the suggested alternatives to the ACR criteria for clinical diagnosis. The survey criteria had been developed on patients with FMS, rheumatoid arthritis (RA), and osteoarthritis (OA) in a rheumatologic practice setting. The items were selected to achieve a maximum discrimination between patients with FMS against patients with RA and OA. However, 29% of the patients with RA and 33% of the patients with OA also fulfilled the survey criteria of FMS. 1 Katz et al claimed that the survey method has the advantage that it does not require an additional physical examination. 2 The AWMF criteria had been suggested by a structured consensus of an interdisciplinary panel of experts of all medical and psychologic disciplines engaged in the care of FMS patients and of representatives of FMS-patients. 8 The most frequent symptoms reported by FMS-patients in different settings (>98% of the patients) 11, 12 were chosen by expert consensus for the clinical diagnosis. The choice of symptoms was not determined by the intention to discriminate FMS from other diseases by these symptoms. The main symptoms of FMS, namely musculoskeletal pain, fatigue, and sleep disturbances, are also prevalent in the general population and in other somatic diseases and in depressive disorder-although FMS patients can be clearly differentiated from depressive disorders by the intensity of reported pain and fatigue. 13 The separation of FMS from The exclusion of somatic diseases sufficiently explaining CWP is not required by the survey and ACR criteria, but by the AWMF criteria and a Canadian expert consensus on FMS. 24 The exclusion of somatic diseases sufficiently explaining the symptoms is required for the diagnosis of functional somatic syndromes (eg, irritable bowel syndrome) in other medical disciplines too. 10 Moreover, the evidence of the efficacy of pharmacologic treatment of FMS is based on randomised controlled trials that excluded patients with somatic diseases as potential cause of CWP. 25, 26 Do Alternative Criteria for FMS Change the Clinical Picture of FMS?
Patients with moderate and high levels of somatic and psychologic distress were diagnosed irrespectively of the criteria used in our study. We found some sociodemographic and clinical differences in cases of lacking concordance. Our study showed that the AWMF criteria led more frequently to a diagnosis of FMS in men than the ACR-criteria. This finding is in line with the results of epidemiologic studies. The ACR-criteria are associated with a sex ratio (women to men) of 6 to 8:1 in epidemiologic and clinical studies. Leaving the TP-criterion leads to a more balanced sex ratio. 3 Branco et al reported an estimated prevalence of FMS in the general population of 5 European countries based on positive screens in the London Fibromyalgia Epidemiologic Study Screening of 2.9% with a ratio women to men of 1.7. 5 The prevalence of FMS diagnosed by the RPS in a representative sample of the general German population was 3.8% with an equal ratio of women and men. 27 
Limitations of the Study
The spectrum of medical disciplines involved in the study was not complete, because general practitioners, orthopaedic surgeons, and psychiatrists did not participate. But in contrast to the study of Katz et al, 2 several investigators of different levels of care participated. The study protocol did not involve clinicians without special expertise in FMS. Therefore, no conclusions on the concordance of the diagnostic criteria in these physicians are possible. We chose rates of overall agreement for measure of concordance and did not present k statistics, 28 because the inclusion and exclusion criteria of the study led to a low rate of patients not diagnosed with FMS by at least 1 diagnostic approach. In contrast, the study of Katz et al included 51% of patients with inflammatory rheumatoid disorder or OA. 2 The small numbers of patients who were positive in only 1 diagnostic criterion and the low percentage of male patients limited the power of statistical comparisons of subgroups.
CONCLUSIONS
There is no gold standard for the clinical diagnosis of FMS.
2,29 Doctor's reports for patients with the diagnosis of FMS should therefore, include the diagnostic approach used. Other medical disciplines use different diagnostic approaches for the clinical diagnosis of functional somatic syndromes too, for example the Manning and Rome I, II, and III criteria for irritable bowel syndrome. 30 Until a better clinical case definition of FMS exists, all diagnostic criteria should be interpreted with caution and subject to modification. 29 The ACR criteria seem to be indispensable for clinical studies. The mean TP count of 9 to 10 in our ACR-negative cases suggests that a lower TP count criterion than 11 might be appropriate for the clinical diagnosis of FMS by the ACR-criteria. Katz et al found that a TP count discriminated maximally at a count Z6 for the clinical diagnosis of FMS. 2 AWMF and survey diagnoses do not require TPE which is 1 of the major obstacles for the diagnosis of FMS in nonrheumatologic settings. Thus, AWMF and survey criteria can replace the ACR-criteria for clinical diagnosis of FMS in nonrheumatologic settings. Studies comparing the preference and applicability of the AWMF and survey criteria by nonrheumatologists at all levels of care are necessary to find out if these diagnostic tools meet the needs of nonrheumatologists and possess reasonable sensitivity and specificity. In case the AWMF-criteria will be accepted by nonrheumatologists, studies should be conducted if FMS will be diagnosed earlier by nonrheumatologists and if management and outcome of FMS will improve.
